End-of-day quote
Shenzhen S.E.
18:00:00 2024-05-30 EDT
|
5-day change
|
1st Jan Change
|
6.84
CNY
|
-1.58%
|
|
-7.44%
|
-46.14%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,454
|
1,968
|
1,984
|
2,332
|
1,909
|
1,865
|
Enterprise Value (EV)
1 |
2,067
|
2,368
|
2,265
|
2,454
|
2,253
|
1,978
|
P/E ratio
|
165
x
|
53.6
x
|
-84.4
x
|
9.93
x
|
-50
x
|
-37.4
x
|
Yield
|
0.4%
|
0.45%
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
5.85
x
|
4.7
x
|
18.1
x
|
9.24
x
|
2.99
x
|
15.9
x
|
EV / Revenue
|
8.32
x
|
5.65
x
|
20.7
x
|
9.73
x
|
3.53
x
|
16.9
x
|
EV / EBITDA
|
70.1
x
|
22.5
x
|
-140
x
|
-145
x
|
170
x
|
650
x
|
EV / FCF
|
-1,184
x
|
20.7
x
|
-10.7
x
|
-9.33
x
|
3.8
x
|
7.12
x
|
FCF Yield
|
-0.08%
|
4.83%
|
-9.36%
|
-10.7%
|
26.3%
|
14%
|
Price to Book
|
1.71
x
|
2.02
x
|
2.1
x
|
1.98
x
|
1.57
x
|
1.69
x
|
Nbr of stocks (in thousands)
|
146,842
|
146,842
|
146,842
|
146,842
|
146,842
|
146,842
|
Reference price
2 |
9.900
|
13.40
|
13.51
|
15.88
|
13.00
|
12.70
|
Announcement Date
|
4/24/19
|
4/24/20
|
4/27/21
|
4/29/22
|
4/27/23
|
4/26/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
248.5
|
418.9
|
109.6
|
252.3
|
638.6
|
117.2
|
EBITDA
1 |
29.49
|
105.2
|
-16.21
|
-16.92
|
13.23
|
3.04
|
EBIT
1 |
27.03
|
101.1
|
-24.95
|
-45.41
|
-16.04
|
-30.75
|
Operating Margin
|
10.88%
|
24.13%
|
-22.77%
|
-18%
|
-2.51%
|
-26.24%
|
Earnings before Tax (EBT)
1 |
16.43
|
94.15
|
-21.11
|
391.1
|
-17.66
|
-51.24
|
Net income
1 |
8.828
|
36.65
|
-23.18
|
235.6
|
-37.93
|
-49.63
|
Net margin
|
3.55%
|
8.75%
|
-21.15%
|
93.4%
|
-5.94%
|
-42.35%
|
EPS
2 |
0.0600
|
0.2500
|
-0.1600
|
1.600
|
-0.2600
|
-0.3400
|
Free Cash Flow
1 |
-1.746
|
114.4
|
-212
|
-263.2
|
593.3
|
277.6
|
FCF margin
|
-0.7%
|
27.31%
|
-193.43%
|
-104.32%
|
92.91%
|
236.87%
|
FCF Conversion (EBITDA)
|
-
|
108.78%
|
-
|
-
|
4,484.99%
|
9,131.72%
|
FCF Conversion (Net income)
|
-
|
312.17%
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.0400
|
0.0600
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/24/19
|
4/24/20
|
4/27/21
|
4/29/22
|
4/27/23
|
4/26/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
613
|
400
|
281
|
122
|
344
|
113
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
20.81
x
|
3.804
x
|
-17.34
x
|
-7.233
x
|
26
x
|
37.07
x
|
Free Cash Flow
1 |
-1.75
|
114
|
-212
|
-263
|
593
|
278
|
ROE (net income / shareholders' equity)
|
1.33%
|
4.1%
|
-2.17%
|
19.3%
|
-2.41%
|
-4.43%
|
ROA (Net income/ Total Assets)
|
0.67%
|
2.28%
|
-0.58%
|
-0.88%
|
-0.32%
|
-0.92%
|
Assets
1 |
1,327
|
1,605
|
3,964
|
-26,840
|
11,682
|
5,396
|
Book Value Per Share
2 |
5.780
|
6.640
|
6.430
|
8.030
|
8.300
|
7.500
|
Cash Flow per Share
2 |
3.400
|
1.970
|
0.4500
|
3.270
|
0.0900
|
0.3200
|
Capex
1 |
1.16
|
0.33
|
0.14
|
2.12
|
2.82
|
0.03
|
Capex / Sales
|
0.47%
|
0.08%
|
0.13%
|
0.84%
|
0.44%
|
0.03%
|
Announcement Date
|
4/24/19
|
4/24/20
|
4/27/21
|
4/29/22
|
4/27/23
|
4/26/24
|
|
1st Jan change
|
Capi.
|
---|
| -46.14% | 141M | | -8.41% | 8.87B | | -3.78% | 1.35B | | -9.55% | 1.32B | | -11.09% | 1.11B | | -20.27% | 821M | | +0.43% | 445M | | +0.90% | 428M | | -54.07% | 351M | | -25.71% | 324M |
Medical Equipment Wholesale
|